Bartha Maria Knoppers Ph.D.

Recent Publications

  1. Ozdemir V., Joly Y., Kirby E., Avard D., Knoppers B.M. Beyond ELSIs - Where to From Here? From 'Regulating' to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. Lam Y.W.F., Cavallari L. (Editors), (Amsterdam: Elsevier, 2013)
  2. McClellan K.A, Avard D., Simard J., Knoppers B.M. Personalized Medicine and Access to Health Care: Potential for Inequitable Access? (2013) 21:2 European Journal of Human Genetics, 143
  3. Knoppers B.M., Deschênes M., Zawati M.H., Tassé A.M. Population studies: return of research results and incidental findings Policy statement. (2013) 21:3 European Journal of Human Genetics, 245
  4. Knoppers B.M., Rioux A. and Zawati, M.H. Pediatric research ‘personalized’? International perspectives on the return of results. (2013)10:1 Personalized Medicine, 89
  5. Fernandez C.V., Strahlendor C., Avard D., Knoppers B.M., O'Connell C., Bouffet E., Malkin D., Jabado N., Boycott K., Sorensen P.H. Attitudes of Canadian Researchers Toward the Return to Participants of Incidental and Targeted Genomic Findings Obtained in a Pediatric Research Setting. (2013) 15:7 Genetics Medicine, 558
  6. Dove E.S., Avard D., Black L., Knoppers B.M. Emerging Issues in Paediatric Health Research Consent Forms in Canada: Working Towards Best Practices. (2013) 14:1 BMC Medical Ethics, 1
  7. Wall Warner A., Bienfait K.L., Bledsoe M., Burckart G., Flamion B., Knoppers B.M., Nelsen A.J., Rudman A., Sieffert N.J., Uyama Y. Improving Clinical Trial Sampling for Future Research - An International Approach: Outcomes and Next Steps from the DIA Future Use Sampling Workshop 201. (2013) 14:1 Pharmacogenomics, 103
  8. Ozdemir V, Avard D, Knoppers BM. Case discussion in response to worldwide and local anti-Malaria initiatives. (2013) Population and Public Health Ethics: Cases from Research, Policy, and Practice, Canadian Institutes of Health Research – Institute of Population and Public Health. University of Toronto Joint Centre for Bioethics: Toronto, ON.
  9. Ozdemir V, Knoppers BM. From government to anticipatory governance: Responding to challenges set by emerging technologies and innovation. Governance for Health in the 21st Century. Kickbusch, I. (Editor). (New York: Springer, 2013).
  10. Sénécal K., Lévesque E., Fernandez C., Tassé A.M., Zawati M.H., Knoppers B.M., Avard D. RMGA Statement of Principles on the Return of Research Results and Incidental Findings. (Montréal, RMGA, 2013)
  11. Ozdemir V., Borda-Rodriguez A., Dove E.S., Ferguson L.R., Huzair F., Manolopoulos V.G., Masellis M., Milius D., Warnich L., Srivastava S. Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation. (2013) 11:1 Current Pharmacogenomics and Personalized Medicine, 1-4.
  12. Joly Y., Ngueng-Feze I., Simard J. Genetic Discrmination and Life Insurance: A Systematic Review of the Evidence. (2013) 11:25 BMC Medicine, 1
  13. McClellan K.A., Kleiderman E., Black L., Bouchard K., Dorval M., Simard J., Knoppers B.M., Avard D. Exploring Resources for Intrafamilial Communication of Cancer Genetic Risk: We Still Need to Talk. (2013) 21:9 European Journal of Human Genetics, 903
  14. Black L., McClellan K., Avard D., Knoppers B.M. Intrafamilial Disclosure of Risk for Hereditary Breast Cancer: Points to Consider. (2013) 4:2 Community Genetics, 203
  15. Knoppers B.M. Privacy, Confidentiality, and Health Research. (2013) 42:1 International Journal of Epidemiology, 359
  16. Black L., Batist G., Avard D., Rousseau C., Diaz Z., Knoppers B.M. Physician Recruitment of Patients to Non-therapeutic Oncology Clinical Trials: Ethics Revisited. (2013) 4 Frontiers in Pharmacology, doi: 10.3389/fphar.2013.00025,
  17. Knoppers B.M., Chisholm R.L., Kaye J., Cox D., Thorogood A., Burton P., Brookes A.J., Fortier I., Goodwin P., Harris J.R., Hveem K., Kent A., Little J., Riegman P.H.J., Ripatti S., Stolk R.P. A P3G Generic Access Agreement for Population Genomic Studies. (2013) 31:5 Nature Biotechnology, 384
  18. van El C.G., Cornel M.C., Borry P., Hastings R.J., Fellmann F., Hodgson S.V., Howard H.C., Cambon-Thomsen A., Knoppers B.M., Meijers-Heijboer H., Scheffer H., Tranebjaerg L., Dondorp W., de Wert G.M.W.R. Whole-genome sequencing in health care. (2013) 21:6 European Journal of Human Genetics, 580
  19. Knoppers B.M., Thorogood A., Chadwick R. The Human Genome Organisation: Towards Next-generation Ethics. (2013) 5:4 Genome Medicine, 1
  20. Budin-Ljøsen I., Soye K.J., Tassé A.M., Knoppers B.M., Harris J.R. Genotype-driven Recruitment: A Strategy whose Time has Come? (2013) 6:1 BMC Medical Genomics, 19
  21. Black L., Avard D., Zawati M.H., Knoppers B.M., Hébert J., Sauvageau G. Funding Considerations for the Disclosure of Genetic Incidental Findings in Biobank Research. (2013) Clinical Genetics, doi: 10.1111/cge/12190
  22. Joly Y., Knoppers B.M. Ethics and Genetics. Brenner's Encyclopedia of Genetics (Oxford: Elsevier, 2013)
  23. Budin-Ljøsne I., Isaeva J., Knoppers B.M., Tassé A.M., Shen H.-Y., McCarthy M.I., ENGAGE Consortium and Harris J.R. Data sharing in large research consortia: experiences and recommendations from ENGAGE. (2013) European Journal of Human Genetics, doi:10.1038/ejhg.2013.1311-5 (advance online publication)1
  24. Knoppers B.M., Avard D., Sénécal K., Zawati M.H. along with the P3G International Paediatrics Platform members. Return of whole-genome sequencing results in paediatric research: a statement of the P3G international paediatrics platform. European Journal of Human Genetics, advance online publication, 7 August 2013; doi:10.1038/ejhg.2013.176; corrigendum, 2013 European Journal of Human Genetics, advance online publication, doi: 1038ejhg.2013.225
  25. Sénécal K., Lévesque E., Fernandez C., Tassé A.M., Zawati M.H., Knoppers B.M., Avard D. Énoncé de principes du RMGA sur la communication des résultats de recherche et des découvertes fortuites
  26. Knoppers B.M. From Tissues to Genomes. (2013) 3:8 G3 Genes, Genomes, Genetics, 1203
  27. Burke W., Matheny Antommaria A.H., Bennett R., Botkin J., Clayton E.W., Henderson G.E., Holm I.A., Jarvik G.P., Khoury M.J., Knoppers B.M., Press N.A., Ross L.F., Rothstein M.A., Saal H., Uhlmann W.R., Wilfond B., Wolf S.M., Zimmern B. Recommendations for Returning Genomic Incidental Findings? We Need to Talk! (2013)Genetics in Medicine, doi: 10.1038/gim.2013.113 (advance online publication)
  28. Mascalzoni D., Knoppers B.M., Aymé S., Macilotti M., Dawkins H., Woods S., Hansson M.G. Rare Diseases and Now Rare Data? (2013) 14:6 Nature Reviews. Genetics, 372
  29. Zawati MH, Parry D, Thorogood A, Nguyen MT, Boycott K, Rosenblatt D, Knoppers BM. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada? (2013) Journal of Medical Genetics, doi: 10.1136/jmedgenet-2013-101934
  30. Knoppers BM, Dove ES, Zawati MH. Demystifying Biobanks. (2013)43:5 Hastings Center Report 4-5
  31. Joly Y., Burton H., Knoppers B.M., Ngueng Feze I., Dent T., Pashayan N., Chowdhury S., Foulkes W., Hall A., Hamet P., Kirwan N., Macdonald A., Simard J., Van Hoyweghen V. Life insurance: genomic stratification and risk classification. (2013) European Journal of Human Genetics, 1
  32. Dove E.S., Black L., Avard D., Knoppers B.M. Charting the Privacy Landscape in Canadian Paediatric Biobanks. Health Law Journal 20; 1-46 (2013)
  33. Knoppers B.M., Rioux A. and Zawati, M.H. “Pediatric research ‘personalized’? International perspectives on the return of results”. (2013)10:1 Personalized Medicine, 89
  34. Knoppers B.M., Zawati M.H. Biobanks. Encyclopedia of Applied Ethics 2nd Edition (San Diego: Academic Press, 2012),246-250.
  35. Zawati M.H., Knoppers B.M. International normative perspectives on the return of individual research results and incidental findings in genomic biobanks. (2012) 14:4 Genetics in Medicine, 484
  36. Ozdemir V., Joly, Y., Dove, E.S., Karalis, A., Avard, D., Knoppers, B.M. Are we asking the right ethics questions on drug shortages? Suggestions for a global and anticipatory ethics framework. (2012) 12:1 American Journal of Bioethics 13-15.
  37. Ozdemir V., Joly Y., Kirby E., Avard D., Knoppers B.M. Beyond ELSIs - Where to From Here? From 'Regulating' to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine. Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation. Lam Y.W.F., Cavallari L. (Editors), (Amsterdam: Elsevier, 2012)
  38. Knoppers B.M., Zawati M.H., Kirby E.S. Sampling Populations of Humans Across the World: ELSI Issues. (2012) 13:1 The Annual Review of Genomics and Human Genetics,1–1.19
  39. Dandara C., Adebamowo C., de Vries J., Dove E.S., Fisher E., Gibbs R.A., Hotez P.J., Kickbusch I., Knoppers B.M., Masellis M., Oestergaard M.Z., Pang T., Rotimi C.N. An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science. (2012) 10:1 Current Pharmacogenomics and Personalized Medicine, 7-15.
  40. Reist C., Wu J.C., Lilja Y., Mukherjee J., Gripeos D., Constantinescu C., Raggi M.A., Mercolini L., Ozdemir V. Ketoconazole-Associated Preferential Increase in Dopamine D2 Receptor Occupancy in Striatum Compared to Pituitary In Vivo: Role for Drug Transporters? (2012) 32:1 J. Clin. Psychopharmacology, 110.
  41. Ozdemir V., Fisher E, Dove E.S., Burton H., Wright G.E.B., Masellis M., Warnich L. End of the Beginning and Public Health Pharmacogenomics: Knowledge in ‘Mode 2’ and P5 Medicine. (2012) 10:1 Current Pharmacogenomics and Personalized Medicine, 1-6
  42. Wolf S.M., Crock B.N., Van Ness B., et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. (2012) 14:4 Genetics in Medicine, 361
  43. Ekström L., Gök E., Johansson M., Garle M., Rane A., Schulze J.J. Doping and Genetic Testing: Sex Difference in UGT2B15 Expression, Testosterone Glucuronidation Activity and Urinary Testosterone/Epitestosterone Glucuronide Ratio. (2012) 10: 2 Current Pharmacogenomics and Personalized Medicine 138.
  44. Zawati M.H. Les conseillers en génétique et les professions médicales et infirmières au Québec: des frontières brouillées ? (2012) 6:1 MJLH 137
  45. Allen C., Foulkes W.D. Qualitative thematic analysis of consent forms used in cancer genome sequencing. (2011) 12 BMC Medical Ethics, 14.
  46. Thorogood A., Knoppers B.M., Dondorp W.J., De Wert G.M.W.R. Whole-genome sequencing and the physician. (2012) 81 Clinical Genetics, 511
  47. Dove E.S., Joly Y., Knoppers B.M. Power to the people: a wiki-governance model for biobanks. (2012) 13:5 Genome Bioliogy: 158.
  48. Joly Y., Livingstone A., Dove E.S. Moving Beyond Commercialization: Strategies to Maximize the Economic and Social Impact of Genomics Research. Genome Canada Policy Brief No. 5 (2012) GE3LS Series, 1–14.
  49. Dove E.S., Joly Y. The Contested Futures of Biobanks and Intellectual Property. (2012) 11:1 Teoria & derecho: revista de pensamiento juridico (Theory & Law: Journal of Legal Thought) 132-146.
  50. Greenberg, C., K.A. McClellan, & D. Avard. A Knowledge Translation Model to Drive Change in Paediatric Genetics. (2012) Beyond Dissemination: A Knowledge Translation Model to Drive Change in Paediatric Genetics. Journal of Pediatric Genetics. 1:7-11.
  51. McClellan K.A, D. Avard, J. Simard & B.M. Knoppers. Personalized Medicine and Access to Health Care: Potential for Inequitable Access? (2012) European Journal of Human Genetics. Accepted June 13, 2012.
  52. Knoppers B.M., Deschênes M., Zawati M.H., Tassé A.M. Population studies: return of research results and incidental findings Policy statement. (2012) European Journal of Human Genetics, doi: 10.1038/ejhg.2012.152.
  53. Joly Y., Dove E.S., Knoppers B.M., Bobrow M., Chalmers D. Data Sharing in the Post-Genomic World: The Experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO). (2012) PLoS Computational Biology 8(7): e1002549.
  54. Kolker E., Stewart E., Ozdemir V. DELSA Global for ‘‘Big Data’’ and the Bioeconomy: Catalyzing Collective Innovation. (2012) 8:3 Industrial Biotechnology.
  55. Zawati M.H., Rioux A. Les biobanques et le retour des résultats de recherche : quo vadis ? (2012) Actions pour la santé et la recherche médicale en faveur des personnes vulnérables et des pays émergents - VIe Forum des jeunes chercheurs
  56. Bombard Y., Miller F.A., Hayeems R.Z., Carroll JC, Avard D., Wilson B.J., Little J, Bytautas J.P., Allanson J., Axler R., Giguere Y., Chakraborty P. Citizens' Values Regarding Research with Stored Samples from Newborn Screening in Canada. (2012) 129:2 Official Journal of the American Academy of Pediatrics, p.239.
  57. Budin-Ljøsne I., Harris J.R., Kaye J., Knoppers B.M., Tassé A.M., Bravo E., Cambon-Thomsen A., Eriksson M., Kyvik K.O., Litton J.-E., Perola M., Rial-Sebbag E. ELSI challenges and strategies of national biobanks infrastructures. (2012) 21:2 Norwegian Journal of Epidemiology, p. 155.
  58. Harris J.R., Burton P., Knoppers B.M, et al. Toward a roadmap in global biobanking for health. (2012) European Journal of Human Genetics, 1
  59. Kaye J., Meslin E.M., Knoppers B.M., et al. ELSI 2.0 for Genomics and Society. (2012) 336:6082 Science Magazine, 673
  60. Knoppers B.M. Paediatric research and the communication of not-so incidental findings. (2012) 17:4 Paediatric Child Health Journal, 190
  61. Knoppers B.M., Avard D., Sénécal K. Newborn screening programmes: Emerging biobanks? (20120 21:2
  62. Knoppers B.M., Avard D., Thorogood A. Informed consent in genetics. (2012) John Wiley & Sons, 1
  63. Madadi P., Avard D., Koren G. Pharmacogenetics of Opioids for the Treatment of Acute Maternal Pain During Pregnancy and Lactation. (2012) 13:6 Current Drug Metabolism, 721
  64. Murtagh M.J., Thorisson G.A., Wallace S.E., ... Knoppers B.M. et al. Navigating the perfect [data] storm. (2012) 21:2 Norwegian Journal of Epidemiology, 203
  65. Wilson B.J., Carroll J.C., Allanson J., ... Avard D. et al. Family History Tools in Primary Care: Does One Size Fit All. (2012) 15:3-4 Public Health Genomics, 181
  66. Ozdemir V., Cho W.C.S. Theranostics: Rethinking Postgenomics Diagnostics. (2012) 12:8 Expert Review of Molecular Diagnostics
  67. Wallace S., Lazor S., Knoppers, B.M. What is in a Clause? A Comparison of Clauses from Population Biobank and Disease Biobank Consent Materials. Trust in Biobanking (Berlin: Springer-Verlang, 2012)
  68. Wallace, S., Knoppers, B.M. The Role of P3G in Encouraging Public Trust in Biobanks. Trust in Biobanking (Berlin: Springer-Verlag, 2012)
  69. Faraj S.A., Kolker E., Bevilacqua L., Ozdemir V. Collective theranostics and post-genomics entrepreneurship: Rethinking innovations as knowledge ecosystems built by complex collaboration. (2012) 12:8 Expert Review of Molecular Diagnostics.
  70. Dove E.S., Ozdemir V., Joly Y. Harnessing Omics Sciences, Population Databases, and Open Innovation Models for Theranostics-Guided Drug Discovery and Development. (2012) Drug Development Research DOI: 10.1002/ddr.21035
  71. Prainsack B., Dove E.S., Ozdemir V. Interview article: Barbara Prainsack (Dept of Sociology, Brunel University, UK): Direct-to-consumer theranostics, 21st century collective innovation and entrepreneurship. (2012) 12:8 Expert Review of Molecular Diagnostics
  72. Knoppers B.M., Dam A. Return of results: towards a lexicon? (2011) 39:4 J. Law Med. Ethics, 577
  73. Dove ES, Faraj SA, Kolker E, Ozdemir V. Designing a post-genomics knowledge ecosystem to translate pharmacogenomics to public health action. (2012) Genome Medicine
  74. Pang T, Dove ES, Ozdemir V. Interview Article: Tikki Pang (National University of Singapore) "Theranostics, the 21st century bioeconomy and ‘one health’". (2012) Expert Review of Molecular Diagnostics 12(8)
  75. Dove E.S., Ozdemir V. 'Regular science' is inherently political. (2012) 13:12 EMBO Reports (Science and Society) doi:10.1038/embor.2012.205.
  76. Zawati MH, Van Ness B et Knoppers BM. Les découvertes fortuites dans la recherche en génomique: une revue des normes internationales. (2011) 9:1 GenEdit 1
  77. Zawati MH, Van Ness B and Knoppers BM. Incidental findings in genomic research: a review of international norms. (2011) 9:1 GenEdit 1
  78. Knoppers B.M., Isasi R., Benvenisty N., et. al. Publishing SNP Genotypes of Human Embryonic Stem Cell Lines: Policy Statement of the International Stem Cell Forum Ethics Working Party. (2011) Stem Cell Rev and Rep, doi 10.1007/s12015-010-9226-2
  79. Knoppers, B.M., Zawati, M.H. Population Biobanks and Access. in S. Rodota, P. Zatti (eds.), Il Governo del Corpo: Trattato di Biodiritto, Giuffrè Editore, 1181-1194
  80. Pathmasiri S., Deschênes M., Joly Y., Mrejen T., Hemmings F., Knoppers B.M. Intellectual property rights in publicly funded biobanks: much ado about nothing? (2011) 29:4 Nature Biotechnology, 319
  81. Ozdemir V., Smith C., Bongiovanni K., Cullen D., Knoppers B.M., Lowe A., Peters M., Robbins R., Stewart E., Yee G., Yu Y-K., Kolker E. Policy and Data-Intensive Scientific Discovery in the Beginning of the 21st Century. (2011) 15:4 OMICS: A Journal of Integrative Biology, 221
  82. Samuël J., Knoppers B.M., Avard D. Medical Research Involving Children: A Review of International Policy Statements. Health Care Ethics: Core and Emerging Issues (London: SAGE, 2011)
  83. Ozdemir V., Muljono D.H., Pang T., Ferguson L.R., Manamperi A., Samper S., Someya T., Tassé A.M., Tsai S.-J., Zhou H.-H., Lee E.J.D. Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine. (2011) 9:1 Current Pharmacogenomics and Personalized Medicine, 1
  84. Howard H.C., Joly Y., Avard D., Laplante N., Phillips M., Tardif J.C. Informed consent in the context of pharmacogenomic research: ethical considerations. (2011) Pharmacogenomics Journal advance online publication 29 March 2011
  85. Madadi P., Joly Y., Avard D., Chitayat D.C., Smith M.A., Ross C.J.D., Carleton B.C., Hayden M.R., Koren G. The Communication of Pharmacogenetic Research Results: Participants Weigh in on Their Informational Needs in a Pilot Study. (2011) 18:1 Journal of Population Therapeutics and Clinical Pharmacology, e152
  86. Joly Y., Tassé, A.M. Balancing Privacy Protections with Open, Collaborative, Biomedical Research. (Ottawa, CIHR, 2011)
  87. Borry P., Henneman L., Lakeman P., Ten Kate L.P., Cornel M.C., Howard H. Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. (2011) 26:5 Human Reproduction 972
  88. Ozdemir V., Knoppers B.M. Future Outlook: Emerging Innovative Approaches for Effective Integration of Medical Research in Clinical Practice. Forward Look: Implementation of Medical Research in Clinical Practice (Strasbourg: European Science Foundation, 2011) 58
  89. Ozdemir V., Joly Y., Knoppers B.M. ACCE, Pharmacogenomics, and Stopping Clinical Trials: Time to Extend the CONSORT Statement? (2011) 11:3 American Journal of Bioethics 11
  90. Su Y., Howard H.C., Borry P. Users’ motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories.. (2011) 2:3 Journal of Community Genetics 135
  91. Tassé A.M., Knoppers B.M. Governance and Use of Previously Stored Human Biological Material in the Public Health Context: Legal and Ethical Issues. (Ottawa, PHAC, 2011)
  92. Tassé A.M., Knoppers B.M. Guidance for Biobanking: Anonymization and Disposal of Human Biological Materials from Existing Collection. (Ottawa, Health Canada, 2011)
  93. Joly Y., Koutrikas G., Tassé A.M., Issa A., Carleton B., Hayden M., Rieder M.J., Ramos-Paque E., Avard D. Regulatory Approval for New Pharmacogenomics Tests: A Comparative Overview. (2011) 66:1 Food and Drug Law Journal, 1
  94. Sénécal K., Giguère Y., Bouffard C., Avard D. Le dépistage néonatal de l’anémie falciforme : enjeux de santé publique, d’éthique et particularités ethniques au Québec. (2011) 33 Sociologie Santé, 293
  95. Brand A., Knoppers B.M., Ambrosino E. Public Health Genomics Journal: Adjusting the Agenda to Future Needs. (2011) 14:3 Public Health Genomics, 125
  96. Howard H.C., Avard D., Borry P. Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms? (2011) 19:11 European Journal of Human Genetics 1122
  97. Zawati M.H., Borry P., Howard H.C. Closure of population biobanks and direct-to-consumer genetic testing companies. (2011) 130:3 Human Genetics 425
  98. Zawati M.H., Hendy M., Joly Y. Incidental Findings in Data Intensive Postgenomics Science and Legal Liability of Clinician-Researchers: Ready for Vaccinomics? (2011) 15:9 OMICS, DOI: 10.1089/omi.2010.0137
  99. Cambon-Thomsen A., Thorisson G.A. and Mabile L. for the BRIF workshop group (including Zawati, M.H.). The role of a bioresource research impact factor as an incentive to share human bioresources. (BRIF workshop group: Andrieu S., Bertier G., Boeckhout M., Carpenter J., Dagher G., Dalgleish R., Deschênes M., di Donato J.H., Filocamo M., Goldberg M., Hewitt R., Hofman P., Kauffman F., Leitsalu L, Lomba I., Melegh B., Metspalu A., Miranda L., Napolitani F., Oestergaard M.Z., Parodi B., Pasterk M., Reiche A., Rial-Sebbag E., Rivalle G., Rochaix P., Susbielle G., Tarasova L., Thomsen M., Zawati M.H., Zins M.) (2011) 43 Nat. Genet., 503
  100. Joly Y., Koutrikas G., Ramos-Paque E., Zawati M.H., Gardy J. Diagnostic Testing for Vaccinomics: Is the Regulatory Approval Framework Adequate? A Comparison of Canada, the United States and Europe. (2011) 15:9 OMICS,DOI: 10.1089/omi.2010.0135
  101. Knoppers B.M., Harris J.R., Tassé A.M., Budin-Ljøsne I., Kaye J., Deschênes M., Zawati M. Towards a data sharing Code of Conduct for international genomic research. (2011) 3:7 Genome Medicine, 1-4
  102. Tassé A.M. Biobanking and deceased persons. (2011) 130 Hum Genet, 415
  103. Zawati M.H., Knoppers B.M., Rioux A. Guidance for Biobanks: Models of Consent for Public Health. Report submitted to the Public Health Agency of Canada (PHAC), 18 March 2011
  104. Knoppers B.M., Zawati M.H. De l'éthique et des avocats: les comités d'éthique dans le milieu hospitalier. in Éthique, profession juridique et société - Collection de droit 2011-2012, volume hors série, École du Barreau (Cowansville: Éditions Yvon Blais, 2011)
  105. Hens K., Lévesque E., Dierickx K. Children and biobanks: a review of the ethical and legal discussion. (2011) 130 Hum Genet, 403-413
  106. Kimmelman J,. McDonald M., Avard D. A Guide to the Perplexed: How to Nagivate Conflicting Research Ethics Policies. (2011) 19:3 Health Law Review, 56
  107. Cox S., Ross K., Townsend A., Avard D., Woodgate R. From Stakeholders to Shareholders: Engaging Consumers in Health Research. (2011) 19:3 Health Law Review, 63
  108. Reddy P.J., Jain R., Paik Y.K., Downey R., Ptolemy A.S., Ozdemir V., Srivastava S. Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology. (2011) 9:3 Current Pharmacogenomics and Personalized Medicine, 159
  109. Kamal S.M., Warnich L., Ferguson L.R., Srivastava S., Ray S., Avard D., Joly Y., Huynh M.L., Page M., Masellis M., Dove E.S., Gurwitz D., Ozdemir V. Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health — A Close Up on Africa and Women’s Health. (2011) 9:3 Current Pharmacogenomics and Personalized Medicine, 148.
  110. Ozdemir V., Faraj S.A., Knoppers B.M. Steering Vaccinomics Innovations with Anticipatory Governance and Participatory Foresight. (2011) 15:9 OMICS, doi:10.1089/omi.2011.0087.
  111. Ozdemir V., Pang T., Knoppers B.M., Avard, D., Faraj S.A., Zawati M.H., Kolker E. Vaccines of the 21st Century and Vaccinomics: Data-Enabled Science Meets Global Health to Spark Collective Action for Vaccine Innovation. (2011) 15(9) OMICS, doi:10.1089/omi.2011.03ed.
  112. Dubé L., Beauvais J., Bertorelli E., Drager N., Kirton J., Ozdemir V. A Must For UN Summit to Have a Fighting Chance Against NCDs: Getting Serious About Business Engagement and Cross-Sector and GloCal Collaboration. (2011) Sept 16th. Global Health Diplomacy Network (GHD-NET)
  113. Dubé L., Bertorelli E., Blouin C., Kirton J., Drager N., Beauvais J., Ozdemir V. Should the G20 Summit Respond to the Call of the UN Summit on NCDs? A Full Fledged Whole-of-Society Approach to NCDs Prevention and Control. (2011) Nov 3rd. Global Health Diplomacy Network (GHD-NET)
  114. Joly, Y., Levesque E., Simard J. Return of research results: General principles and international perspectives. (2011) 39:4 Journal of Law Medicine and Ethics, 583
  115. Dove E.S., Knoppers B.M., Joly, Y. Trade-Secret Model: Legal Limitations. (2011)333:6049 Science, 1575
  116. Joly, Y. Personalized Medicine in Developing Countries: A Roadmap to Personalized Innovation. (2011)9:3 Current Pharmacogenomics and Personalized Medicine, 156-158
  117. Joly, Y., Zepps N., Knoppers B.M. Genomic Databases Access Agreements: Legal Validity and Possible Sanctions. (2011)130:3 Human Genetics, 441–449
  118. Ozdemir V., Rosenblatt D., Warnich L., Srivastava S., Tadmouri G., Aziz R., Reddy P., Manamperi A., Dove E.S., Joly Y., Zawati M., Hizel C., Yazan Y., John L., Vaast E., Ptolemy A., Faraj S., Kolker E., Cotton R.G.H. Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA). (2011) 9:4 Current Pharmacogenomics and Personalized Medicine, 243-251.
  119. Dove E.S. The Genetic Privacy Carousel: A Discourse on Proposed Genetic Privacy Bills and the Co-Evolution of Law and Science. (2011) 9:4 Curr. Pharmacogenomics Person. Med., 252
  120. Ngueng-Feze I, Borda-Rodriguez A, Huzair F. Not So Simple: Situating Postgenomics Personalized Medicine in the Regional Context in Africa for Global and Women's Health. (2011) 9:4 Current Pharmacogenomics and Personalized Medicine, 332.
  121. Zawati MH, Rioux A. Biobanks and the Return of Research Results: Out with the Old and In with the New? (2011) 39:4 JLME, 614-620
  122. Grizzle W.E., Knoppers B.M., Zeps N., Hewitt S.M., Sullivan K. What Are the Most Oppressing Legal and Ethical Issues Facing Biorepositories and What are Some Strategies to Address Them? (2011)9:4 Biopreservation and Biobanking, 317-319.
  123. Senecal K., Giguere Y., Bouffard C., Avard D. Le dépistage néonatal de l'anémie facilfoforme: enjeux de santé publique, d'éthique et particularités ethniques au Québec. (2011)33 Sociologie Santé, 293-310
  124. Black, L., K.A. McClellan. Familial Communication of Research Results: A Need to Know? (2011) Journal of Law Medicine and Ethics.39:605-13
  125. De Wert G.M.W.R., Dondorp W.J., Knoppers B.M. Preconception care and genetic risk: ethical issues. 2011, Journal of Community Genetics, (open access)
  126. Knoppers B.M., Lévesque E. Introduction. Return of Research Results: How Should Research Results be Handled? (2011) 39:4 Journal of Law, Medicine and Ethics, 574
  127. Lévesque E., Joly Y., Simard J. Return of research results: General principles and international perspectives. (2011) 39:4 Journal of Law, Medicine and Ethics, 583.
  128. Lévesque E., Knoppers B.M. Principes assurant la protection des enfants participant à des biobanques : du stade prénatal jusqu'aux adolescents. (2011) 5:2 Revue de droit et santé de McGill, 163. http://www.genomicsandpolicy.org/en/publications/Knoppers/9